Billy AMZAL

CEO at Quinten Health

Billy AMZAL has a diverse work experience spanning over two decades. Billy most recently served as the CEO at Quinten Health since September 2020. Prior to that, they held the role of Senior Scientific Vice President, LA-SER Analytica at LA-SER Group from September 2011 to January 2021. From January 2010 to August 2011, Billy was the Director of Data Center at the Program for HIV Prevention and Treatment. Billy also worked at the European Food Safety Authority (EFSA) as a Scientific Officer and Deputy Head of Unit from December 2006 to December 2009. Before that, they held the position of Senior modeler and project manager at Novartis from December 2004 to December 2006. Billy began their career as a Scientific Administrator and Consultant at INERIS / Ministry of Agriculture from September 1999 to December 2004.

Billy AMZAL completed their education as follows:

- From 2001 to 2004, Billy attended Université Paris Dauphine - PSL, where they obtained a PhD in statistics.

- In 2000 and 2001, Billy studied at Pierre and Marie Curie University, earning a DEA (Diplôme d'Études Approfondies) in Probabilités et Statistiques (Probability and Statistics).

- Between 1999 and 2001, Billy was enrolled in AgroParisTech. However, no specific degree or field of study is provided.

- From 1996 to 1999, Billy attended École Polytechnique but did not mention any specific degree or field of study.

- Prior to École Polytechnique, Billy studied at Lycée Louis-le-Grand from 1993 to 1996, focusing on Classes Prépa (Preparatory Classes).

Additional information about Billy's education is not available as the start and end years, as well as the school names, are not provided for certain entries.

Links

Previous companies

Novartis logo

Timeline

  • CEO

    September, 2020 - present